KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,560.00
+15.00 (0.42%)
Feb 21, 2025, 9:00 AM KST

KUKJEON PHARMACEUTICAL Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21
Market Capitalization
174,686306,192324,839537,308
Market Cap Growth
-28.61%-5.74%-39.54%-
Enterprise Value
180,765319,290284,635-
Last Close Price
3560.006240.006609.1510932.05
PE Ratio
26.5663.4736.30133.06
PS Ratio
1.302.513.136.30
PB Ratio
1.763.143.526.46
P/TBV Ratio
2.183.223.606.49
P/OCF Ratio
16.96--176.63
EV/Sales Ratio
1.342.622.74-
EV/EBITDA Ratio
26.5833.1157.72-
EV/EBIT Ratio
94.9349.0581.60-
Debt / Equity Ratio
0.770.810.640.09
Debt / EBITDA Ratio
11.248.1712.031.09
Asset Turnover
0.590.580.68-
Inventory Turnover
4.284.054.62-
Quick Ratio
0.930.941.672.72
Current Ratio
1.171.242.023.52
Return on Equity (ROE)
5.82%4.94%10.12%-
Return on Assets (ROA)
0.54%1.93%1.44%-
Return on Capital (ROIC)
0.72%2.48%1.80%-
Return on Capital Employed (ROCE)
1.56%5.20%2.78%7.18%
Earnings Yield
3.77%1.58%2.75%0.75%
FCF Yield
1.77%-14.46%-9.02%-1.37%
Dividend Yield
0.28%0.16%--
Payout Ratio
7.44%-5.48%-
Buyback Yield / Dilution
4.23%4.23%-16.16%-
Total Shareholder Return
4.51%4.39%-16.16%-
Source: S&P Capital IQ. Standard template. Financial Sources.